Healthy Participants

The Hormone Balance Study

8 night stay, 1 follow up

Help Test a New Potential drug for the Treatment of Congenital Adrenal Hyperplasia (CAH)

This clinical study is evaluating a potential new drug for to treat Congenital Adrenal Hyperplasia.

Congenital Adrenal Hyperplasia is a genetic condition that affects how the adrenal glands make important hormones. The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–32.

Schedule

Cohort 1.2

Check In

Oct 04th

Check Out

Oct 12th

Oct 26th

Cohort 2.1

Check In

Oct 21st

Check Out

Oct 29th

Nov 12th

Cohort 2.2

Check In

Nov 04th

Check Out

Nov 12th

Nov 26th

To Qualify, You Must

New healthy volunteer study coming soon.

Spots are limited. Find out if you qualify today!